Health Catalyst (NASDAQ:HCAT) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Health Catalyst (NASDAQ:HCAT) posted its quarterly earnings results on Monday. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.09), Zacks reports. Health Catalyst had a negative return on equity of 7.21% and a negative net margin of 31.67%. Health Catalyst updated its FY 2025 guidance to EPS and its Q4 2025 guidance to EPS.

Health Catalyst Trading Up 0.7%

HCAT traded up $0.02 on Monday, hitting $2.85. The company had a trading volume of 992,937 shares, compared to its average volume of 693,076. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. The company’s fifty day moving average price is $3.05 and its 200 day moving average price is $3.52. Health Catalyst has a 1 year low of $2.52 and a 1 year high of $9.24. The firm has a market cap of $200.55 million, a P/E ratio of -1.89 and a beta of 1.64.

Institutional Investors Weigh In On Health Catalyst

Several institutional investors and hedge funds have recently modified their holdings of the company. First Light Asset Management LLC lifted its position in Health Catalyst by 17.2% during the 2nd quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock worth $46,108,000 after acquiring an additional 1,793,374 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Health Catalyst by 11.4% in the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after acquiring an additional 169,580 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Health Catalyst by 816.8% in the first quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock valued at $763,000 after acquiring an additional 149,981 shares in the last quarter. Vanguard Group Inc. lifted its position in Health Catalyst by 2.9% in the third quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock valued at $12,243,000 after purchasing an additional 119,117 shares during the period. Finally, Qube Research & Technologies Ltd increased its position in Health Catalyst by 68.4% during the 2nd quarter. Qube Research & Technologies Ltd now owns 282,281 shares of the company’s stock worth $1,064,000 after purchasing an additional 114,626 shares during the period. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Analysts Set New Price Targets

HCAT has been the subject of several recent research reports. Evercore ISI cut their price target on Health Catalyst from $4.00 to $3.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Piper Sandler cut Health Catalyst from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $8.00 to $4.00 in a report on Wednesday, August 27th. Stifel Nicolaus cut their target price on Health Catalyst from $5.50 to $4.50 and set a “hold” rating for the company in a research note on Friday, August 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Health Catalyst in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group dropped their price objective on shares of Health Catalyst from $9.00 to $5.00 and set a “buy” rating for the company in a report on Friday, August 29th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.55.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.